IVB102
/ InnoVec Bio
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
April 30, 2025
IVB102-101: Safety and Efficacy Study of IVB102 Injection in Subjects With X-linked Retinoschisis
(clinicaltrials.gov)
- P1 | N=18 | Active, not recruiting | Sponsor: InnoVec Biotherapeutics Inc. | Recruiting ➔ Active, not recruiting
Enrollment closed • Inherited Retinal Dystrophy • Ophthalmology • Retinal Disorders
May 07, 2024
IVB102-101: Safety and Efficacy Study of IVB102 Injection in Subjects With X-linked Retinoschisis
(clinicaltrials.gov)
- P1 | N=18 | Recruiting | Sponsor: InnoVec Biotherapeutics Inc. | Not yet recruiting ➔ Recruiting
Enrollment open • Inherited Retinal Dystrophy • Ophthalmology • Retinal Disorders
1 to 2
Of
2
Go to page
1